Literature DB >> 26653877

Studies on Aryl-Substituted Phenylalanines: Synthesis, Activity, and Different Binding Modes at AMPA Receptors.

Ewa Szymanska1, Karla Frydenvang1, Darryl S Pickering1, Christian Krintel1, Birgitte Nielsen1, Ayesheh Kooshki1, Linda G Zachariassen1, Lars Olsen1, Jette S Kastrup1, Tommy N Johansen1.   

Abstract

A series of racemic aryl-substituted phenylalanines was synthesized and evaluated in vitro at recombinant rat GluA1-3, at GluK1-3, and at native AMPA receptors. The individual enantiomers of two target compounds, (RS)-2-amino-3-(3,4-dichloro-5-(5-hydroxypyridin-3-yl)phenyl)propanoic acid 37 and (RS)-2-amino-3-(3'-hydroxybiphenyl-3-yl)propanoic acid 38, were characterized. (S)-37 and (R)-38 were identified as the only biologically active isomers, both being antagonists at GluA2 receptors with Kb of 1.80 and 3.90 μM, respectively. To address this difference in enantiopharmacology, not previously seen for amino acid-based AMPA receptor antagonists, X-ray crystal structures of both eutomers in complex with the GluA2 ligand binding domain were solved. The cocrystal structures of (S)-37 and (R)-38 showed similar interactions of the amino acid parts but unexpected and different orientations and interactions of the biaromatic parts of the ligands inside the binding site, with (R)-38 having a binding mode not previously identified for amino acid-based antagonists.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26653877     DOI: 10.1021/acs.jmedchem.5b01666

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  1 in total

1.  Phenylalanine-Based AMPA Receptor Antagonist as the Anticonvulsant Agent with Neuroprotective Activity-In Vitro and In Vivo Studies.

Authors:  Gniewomir Latacz; Kinga Sałat; Anna Furgała-Wojas; Adrian Martyniak; Agnieszka Olejarz-Maciej; Ewelina Honkisz-Orzechowska; Ewa Szymańska
Journal:  Molecules       Date:  2022-01-27       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.